Evidence map›Paper›PMID 42007154›Full record

ArticleAmerican journal of translational research2026

Decision-making value of a 1-cm tumor diameter cut-off for postoperative

Guiwen Zheng, Huimin Guo, Shuzhan Yao, Qiang Jia, Jian Tan, Zhaowei Meng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guiwen ZhengDepartment of Nuclear Medicine, Tianjin Medical University General Hospital Tianjin 300052, China.
Huimin GuoDepartment of Nuclear Medicine, Tianjin Medical University General Hospital Tianjin 300052, China.
Shuzhan YaoDepartment of Nuclear Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan 250021, Shandong, China.
Qiang JiaDepartment of Nuclear Medicine, Tianjin Medical University General Hospital Tianjin 300052, China.
Jian TanDepartment of Nuclear Medicine, Tianjin Medical University General Hospital Tianjin 300052, China.
Zhaowei MengDepartment of Nuclear Medicine, Tianjin Medical University General Hospital Tianjin 300052, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the decision-making value of a 1-cm tumor diameter cut-off for radioactive iodine (

methodsThis retrospective study included 291 patients who received post-operative

resultsCompared to the PTNMC group, the PTMC group showed lower rates of capsular invasion (40.65% vs. 59.52%), extraadenal invasion (12.20% vs. 23.21%), >5 lymph node metastases (38.21% vs. 57.74%), T3b/T4 stage (5.69% vs. 16.07%), pre-therapy sTg ≥10 μg/L (17.89% vs. 37.50%), and high recurrence risk (13.01% vs. 24.40%) (all

conclusionA 1-cm diameter cut-off had limited standalone value in guiding

Indexed as

decision valuediameter thresholdiodine-131 therapyPapillary thyroid microcarcinomapapillary thyroid non-microcarcinoma

Identifiers

PMID42007154
PMCPMC13090874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.